Tolerability of denosumab in metastatic solid tumor patients with renal insufficiency

Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study

Karim Fizazi, Michael A. Carducci, Matthew R. Smith et al. · The Lancet · 2011 · 2K citations · Full text

Medicine, Oncology, Urology +17

Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study

Alison Stopeck, Allan Lipton, Jean-Jacques Body et al. · Journal of Clinical Oncology · 2010 · 1.6K citations

Medicine, Pharmacology, Pharmacotherapy +17

Effects of denosumab on fracture and bone mineral density by level of kidney function

Sophie A. Jamal, Östen Ljunggren, Catherine Stehman‐Breen et al. · Journal of Bone and Mineral Research · 2011 · 352 citations

Medicine, Clinical Sciences, Nephrology +14

American Society of Clinical Oncology Executive Summary of the Clinical Practice Guideline Update on the Role of Bone-Modifying Agents in Metastatic Breast Cancer

Catherine Van Poznak, Sarah Temin, Gary C. Yee et al. · Journal of Clinical Oncology · 2011 · 344 citations · Full text

Medicine, Oncology, Bone Metabolism +16

A single-dose study of denosumab in patients with various degrees of renal impairment

Geoffrey A. Block, Henry G. Bone, Liang Fang et al. · Journal of Bone and Mineral Research · 2012 · 340 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16